{"id":3187,"date":"2016-03-24T13:23:26","date_gmt":"2016-03-24T13:23:26","guid":{"rendered":"http:\/\/www.sib.it\/?p=3187"},"modified":"2018-02-09T09:05:22","modified_gmt":"2018-02-09T09:05:22","slug":"sibprima-march-2016-italy-changes-its-spc-practice-brexit-italy-and-the-upc-mind-your-class-headings","status":"publish","type":"post","link":"https:\/\/www.sib.it\/en\/newsletter\/italy-changes-its-spc-practice-sibprima-2016\/","title":{"rendered":"SIBprima March 2016 – Italy changes its SPC practice – Brexit, Italy and the UPC – Mind your (class) headings!"},"content":{"rendered":"

\"sibp_03_16\"<\/a><\/p>\n

PHARMA PATENTS TERM EXTENSION\u00a0<\/span><\/span><\/p>\n

Change of practice at the Italian PTO on calculation of SPC term<\/h2>\n

A decision of the Board of Appeals of the Italian Patent and Trademark Office applies to Italy the Seattle Generics ruling of the Court of Justice of the European Union, bringing changes in how the Italian PTO calculates the term of supplementary protection certificates.<\/em><\/p>\n

The Italian Patent and Trademark Office (IPTO) must change its practice concerning the calculation of the term of supplementary protection certificates (SPCs) for medicinals.<\/p>\n

The term of SPCs must run from the date of publication<\/em> in the Official Journal of the first marketing authorisation issued in the European Union.<\/p>\n

The term of Italian SPCs had so far been calculated from the date of issue <\/em>of the first marketing authorisation in the European Union for the medicinal product.<\/p>\n

\"Italy<\/a>This, in essence, is the effect of decision No. 11\/16 of 18 February 2016 of the Board of Appeals of the Italian Patent and Trademark Office (the BoA) in an appeal brought by Takeda Pharmaceutical Company Limited.<\/p>\n

The BoA\u2019s decision applies to national SPCs a very recent judgement of the Court of Justice of the European Union (C-471\/14, Seattle Generics vs. the Austrian Patent Office<\/a>). This important judgement clarifies the interpretation of Article 13(1) of Regulation EC 469\/2009 setting forth EU-wide rules on SPCs.<\/p>\n

Article 13(1) provides that the SPC\u2019s term shall take effect at the end of the lawful term of the basic patent for a period equal to the period which elapsed between the date on which the application for a basic patent was lodged and the date of the first authorisation to place the product on the market in the European Union, reduced by a period of five years.<\/p>\n

The judgement has cleared that the words in Article 13(1) \u201cdate of the first authorisation to place the product on the market\u201d must be interpreted as meaning the date on which notification of the decision granting marketing authorisation was given to the addressee of the decision<\/em>.<\/p>\n

The IPTO must therefore calculate the duration of SPCs as from the date of notification to the applicant of the decision to grant the marketing authorisation.<\/p>\n

Such date of notification is the date on which the decision to grant the marketing authorisation is published in the Official Journal of the European Union, or in the Italian Official Journal<\/em> if the first marketing authorisation in the European Union was granted in Italy.<\/p>\n

It should be noted that the Italian Supreme Court in a decision of 1999 took the same position of the Court of Justice of the European Union, almost in the same terms.<\/p>\n

While the IPTO had so far maintained an interpretation aligned with that of other EU countries, the judgement in case C-471\/14 makes it necessary for the IPTO to conform its practice as clarified by the Court of Justice of the European Union.<\/p>\n

Depending on individual circumstances, it could be advisable for holders of SPCs issued by the IPTO or of SPC applications filed with the IPTO to request recalculation of the SPC\u2019s term<\/span> in accordance with this change of practice.<\/p>\n

Please contact us if you have any questions on this change of practice at the IPTO.<\/p>\n

\u00a0—————————————-<\/span><\/h2>\n

UNITARY PATENT<\/span><\/span><\/p>\n

Brexit, Italy and the Unitary patent system<\/h2>\n

If the UK leaves the European Union, Italy\u2019s ratification of the UPC Agreement will become mandatory for the unitary patent system to kick off, and Milan will become a candidate to host the Central Division section of the UPC now based in London.<\/em><\/p>\n

On 23 June 2016 the British will vote in a referendum on whether or not the United Kingdom (UK) should leave the European Union (EU).\u00a0How would an outcome in favour of leaving the EU affect the Unitary patent system?\"Brexit\"<\/span><\/p>\n

UPC ratification<\/span><\/p>\n

Britain, along with France and Germany, is currently one of the three countries whose ratification of the Unified Patent Court Agreement (UPCA) is mandatory for the UPCA, and indeed the Unitary patent, to come into force.<\/p>\n

If Britain were to leave the EU, the country that would replace it in the threesome whose ratification of the UPCA is mandatory would be Italy.<\/p>\n

This is because under Article 89(1) of the UPCA, those three countries are defined as the three EU Member States in which the highest number of European patents had effect in 2012.<\/p>\n

According to the statistics available for 2012, about 45% of European patents were valid in Italy, while only about 30% of them were valid in The Netherlands. Therefore should the UK no longer be a EU Member State it is Italy that would replace the UK, not the Netherlands (as many sources have recently stated).<\/p>\n

UPC Central Division<\/span><\/p>\n

In the event of a Brexit, it is questionable whether London would still be able to host a\u00a0Central Division section of the UPC. Milan would become one of the candidates for the new location, along with Paris, Munich and The Hague.<\/p>\n

\u00a0—————————————-<\/span><\/h2>\n

EUROPEAN PATENTS<\/span><\/span><\/p>\n

European patent applications originating from Italy grew 9% in 2015<\/h2>\n

The\u00a02015 annual report of European Patent Office<\/a> is out. European patent applications went up by 4.8% last year, with the largest share of applications originating from the US, Germany, Japan, France and The Netherlands.<\/p>\n

One notable difference was the +9% jump in European patent applications originating from Italy, which reversed a 4-year negative trend. Italian companies filed just under 4000 applications in 2015, that represent\u00a02% of the total\u00a0and make\u00a0Italy the 10th\u00a0top European patent applicant.<\/p>\n

The increase could be due at least in part to the Italian patent box<\/a> provisions introduced in 2015.<\/p>\n

\u00a0—————————————-<\/span><\/h2>\n

TRADEMARKS IN THE EUROPEAN UNION<\/span><\/span><\/p>\n

Mind your (class) headings! New EU Trademark Regulation overhead<\/h2>\n

Part of the European Union trademark reform package came into force on 23 March 2016: trademark holders and applicants must take note of the change of rules regarding claims for products or services.<\/em><\/p>\n

The new EU Trademark Regulation No. 2015\/2424<\/a>\u00a0came into force on 23 March 2016, bringing changes to both the Community trademark (CTM) system and to the national trademark laws of European Union countries.<\/p>\n

Class headings<\/span><\/p>\n

From the point of view of trademark holders and applicants, the most important change concerns the use of class headings to claim products or services. As from 22\u00a0June\u00a02012, following \u00a0the\u00a0decision <\/a>of the Court of Justice of the European Union in case C-307\/10\u00a0IP Translator, use of a class heading can\u00a0no\u00a0longer be interpreted as providing protection for all products and services in that class. The products and services claimed in the application are to be\u00a0interpreted literally.<\/p>\n

Under the new EU Trademark Regulation, holders of trademarks filed before 22 June 2012 will have a six-month window to amend their claim in order to list precisely what they intended to cover. The window will close\u00a0on 24 September 2016.<\/p>\n

The above applies also to International trademarks designating the European Union.<\/p>\n

From Community to European Union trademark<\/span><\/p>\n

As from 23 March 2016, the Community trademark is\u00a0renamed European Union trademark (EUTM) and the Office for Harmonization in the Internal Market is\u00a0renamed European Union Intellectual Property Office (EUIPO).<\/p>\n

Fees<\/span><\/p>\n

The Community trademark application basic fee included up to three classes of goods. The new EUTM fee schedule sets a separate class fee for each additional class beyond the first, and the same applies for renewals. Thus EUTMs are\u00a0cheaper than CTMs for registration and renewal in a single class, but more expensive for more than one class.<\/p>\n

Customs action against infringing goods<\/span><\/p>\n

Holders of registered trademarks have the right to\u00a0act against infringing products even if they are in transit through the European Union or under suspensive procedure.<\/p>\n

DOs and GIs<\/span><\/p>\n

The rights of \u00a0holders of Denominations of Origin (DOs) and Geographical Indications (GIs) are\u00a0strengthened. It is\u00a0possible to oppose the registration and use of trademarks in the European Union on the basis of rights in DOs and GIs.<\/p>\n

\u00a0—————————————-<\/span><\/h2>\n

EVENTS<\/span><\/span><\/p>\n

Meet us there!<\/h2>\n

\"travel10 April 2016
\nFICPI 2016 Executive Committee Meeting in Zurich<\/a><\/p>\n

21 April 2016
\nUnified Patent Court Mock Trial in Rome<\/a><\/p>\n

21 April 2016
\nAIPPI Women in IP Networking 2016 Italian events<\/a><\/p>\n

21-25 May 216
\nINTA 2016 Annual Meeting in Orlando<\/a><\/p>","protected":false},"excerpt":{"rendered":"

PHARMA PATENTS TERM EXTENSION\u00a0 Change of practice at the Italian PTO on calculation of SPC term A decision of the Board of Appeals of the Italian Patent and Trademark Office applies to Italy the Seattle Generics ruling of the Court of Justice of the European Union, bringing changes in how the Italian PTO calculates the […]<\/p>\n","protected":false},"author":4,"featured_media":3267,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[16],"tags":[],"acf":[],"yoast_head":"\nSIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti<\/title>\n<meta name=\"description\" content=\"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti\" \/>\n<meta property=\"og:description\" content=\"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-24T13:23:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-09T09:05:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"263\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Ercoli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sib.it\/#website\",\"url\":\"https:\/\/www.sib.it\/\",\"name\":\"\",\"description\":\"Intellectual Property since 1882\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sib.it\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg\",\"contentUrl\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg\",\"width\":263,\"height\":160},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#webpage\",\"url\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/\",\"name\":\"SIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti\",\"isPartOf\":{\"@id\":\"https:\/\/www.sib.it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#primaryimage\"},\"datePublished\":\"2016-03-24T13:23:26+00:00\",\"dateModified\":\"2018-02-09T09:05:22+00:00\",\"author\":{\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\"},\"description\":\"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sib.it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"(English) SIBprima March 2016 – Italy changes its SPC practice – Brexit, Italy and the UPC – Mind your (class) headings!\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\",\"name\":\"Laura Ercoli\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"caption\":\"Laura Ercoli\"},\"url\":\"https:\/\/www.sib.it\/en\/author\/lercoli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti","description":"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/","og_locale":"en_US","og_type":"article","og_title":"SIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti","og_description":"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016","og_url":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/","article_published_time":"2016-03-24T13:23:26+00:00","article_modified_time":"2018-02-09T09:05:22+00:00","og_image":[{"width":263,"height":160,"url":"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg","type":"image\/jpeg"}],"twitter_card":"summary","twitter_misc":{"Written by":"Laura Ercoli","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.sib.it\/#website","url":"https:\/\/www.sib.it\/","name":"","description":"Intellectual Property since 1882","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sib.it\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#primaryimage","inLanguage":"en-US","url":"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg","contentUrl":"https:\/\/www.sib.it\/wp-content\/uploads\/2016\/03\/sibp_03_16thmb.jpg","width":263,"height":160},{"@type":"WebPage","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#webpage","url":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/","name":"SIBprima intellectual property newsletter of Societ\u00e0 Italiana Brevetti","isPartOf":{"@id":"https:\/\/www.sib.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#primaryimage"},"datePublished":"2016-03-24T13:23:26+00:00","dateModified":"2018-02-09T09:05:22+00:00","author":{"@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b"},"description":"(English) New rules on pharma patent term extension: Italy changes its SPC practice - Societ\u00e0 Italiana Brevetti newsletter SIBprima March 2016","breadcrumb":{"@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-march-2016\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sib.it\/"},{"@type":"ListItem","position":2,"name":"(English) SIBprima March 2016 – Italy changes its SPC practice – Brexit, Italy and the UPC – Mind your (class) headings!"}]},{"@type":"Person","@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b","name":"Laura Ercoli","image":{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","caption":"Laura Ercoli"},"url":"https:\/\/www.sib.it\/en\/author\/lercoli\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/3187"}],"collection":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/comments?post=3187"}],"version-history":[{"count":1,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/3187\/revisions"}],"predecessor-version":[{"id":5978,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/3187\/revisions\/5978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media\/3267"}],"wp:attachment":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media?parent=3187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/categories?post=3187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/tags?post=3187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}